CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 112 enrolled
Drug / intervention
oxygendrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02273830
NCT02273830Phase 4Completed
CompareCT.gov

Benefits of Liquid Oxygen in COPD Patients Presenting Desaturation on Exercise But Without Conventional Criteria for Domiciliary Oxygen Therapy.

Jtarrega·interventional·Posted Oct 24, 2014·Updated Aug 7, 2018

In Brief

A Phase 4 clinical trial evaluating oxygen for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 112 participants across 1 site.

Detailed Summary

The purpose of this study is analyzed the impact of oxygen adjusted during exercise in COPD patients without conventional for LTOT but with exercise desaturation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesSpain
CollaboratorsFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Hospital Mutua de Terrassa, Hospital Dos de Maig, Hospital Universitari Sant Joan de Reus

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 24, 2014
Enrollment StartSep 1, 2015
Primary CompletionOct 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 11.7 years ago

Interventions

oxygendrug

Oxygen administered after adjustment during a waking test or at 3L/min